Takip et
Jennifer K. Richer
Jennifer K. Richer
ucdenver.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Nuclear receptor coactivators and corepressors.
KB Horwitz, TA Jackson, DL Bain, JK Richer, GS Takimoto, L Tung
Molecular Endocrinology 10 (10), 1167-1177, 1996
12821996
Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells
JK Richer, BM Jacobsen, NG Manning, MG Abel, KB Horwitz, DM Wolf
Journal of Biological Chemistry 277 (7), 5209-5218, 2002
7282002
The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT
TA Jackson, JK Richer, DL Bain, GS Takimoto, L Tung, KB Horwitz
Molecular endocrinology 11 (6), 693-705, 1997
6041997
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
DR Cochrane, S Bernales, BM Jacobsen, DM Cittelly, EN Howe, ...
Breast Cancer Research 16, 1-19, 2014
4542014
Progesterone regulates transcription of the p21WAF1 cyclindependent kinase inhibitor gene through Sp1 and CBP/p300
GI Owen, JK Richer, L Tung, G Takimoto, KB Horwitz
Journal of Biological Chemistry 273 (17), 10696-10701, 1998
4451998
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
DR Cochrane, NS Spoelstra, EN Howe, SK Nordeen, JK Richer
Molecular cancer therapeutics 8 (5), 1055-1066, 2009
4162009
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
EN Howe, DR Cochrane, JK Richer
Breast cancer research 13, 1-15, 2011
3002011
A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer
NC D'Amato, TJ Rogers, MA Gordon, LI Greene, DR Cochrane, ...
Cancer research 75 (21), 4651-4664, 2015
2852015
Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
VN Barton, NC D'Amato, MA Gordon, HT Lind, NS Spoelstra, BL Babbs, ...
Molecular cancer therapeutics 14 (3), 769-778, 2015
2702015
Convergence of progesterone and epidermal growth factor signaling in breast cancer: potentiation of mitogen-activated protein kinase pathways
CA Lange, JK Richer, T Shen, KB Horwitz
Journal of Biological Chemistry 273 (47), 31308-31316, 1998
2581998
Convergence of progesterone with growth factor and cytokine signaling in breast cancer: progesterone receptors regulate signal transducers and activators of transcription …
JK Richer, CA Lange, NG Manning, G Owen, R Powell, KB Horwitz
Journal of Biological Chemistry 273 (47), 31317-31326, 1998
2541998
Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals
CA Lange, JK Richer, KB Horwitz
Molecular Endocrinology 13 (6), 829-836, 1999
2421999
Loss of miR‐200c: a marker of aggressiveness and chemoresistance in female reproductive cancers
DR Cochrane, EN Howe, NS Spoelstra, JK Richer
Journal of oncology 2010 (1), 821717, 2010
2402010
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
DM Cittelly, PM Das, NS Spoelstra, SM Edgerton, JK Richer, AD Thor, ...
Molecular cancer 9, 1-12, 2010
2342010
The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers
NS Spoelstra, NG Manning, Y Higashi, D Darling, M Singh, KR Shroyer, ...
Cancer research 66 (7), 3893-3902, 2006
2142006
Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology
BM Jacobsen, SA Schittone, JK Richer, KB Horwitz
Molecular Endocrinology 19 (3), 574-587, 2005
2042005
MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer
DR Cochrane, DM Cittelly, EN Howe, NS Spoelstra, EL McKinsey, ...
Hormones and Cancer 1, 306-319, 2010
1752010
ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease
M Singh, NS Spoelstra, A Jean, E Howe, KC Torkko, HR Clark, ...
Modern Pathology 21 (7), 912-923, 2008
1702008
Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action
NS Kumar, J Richer, G Owen, E Litman, KB Horwitz, KK Leslie
Cancer research 58 (9), 1860-1865, 1998
1691998
The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity
EN Howe, DR Cochrane, JK Richer
Journal of mammary gland biology and neoplasia 17, 65-77, 2012
1632012
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20